Today, Cerebras Systems, the pioneer in high performance AI compute, smashed its previous industry record for inference, delivering 2,100 tokens/second performance on Llama 3.2 70B. This is 16x faster ...
GSK (GSK) reported its RSV vaccine Arexvy elicited a robust immune response in people aged 18 to 49 years who were at ...
Hosted on MSN6h
GSK’s Arexvy Vaccine Shows Promise for Broader UseGlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...
North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...
Dr. Ernest Mario, the founding chair of the Duke University Health System Board of Directors and a leader in the ...
The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
The Global Non-Small Cell Lung Carcinoma (NSCLC) Market is on the brink of an extraordinary transformation, with market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback